Robert F. Kennedy Jr., a vocal vaccine critic, has been formally appointed as the U.S. Secretary of Health and Human Services. His nomination has caused huge controversy, as he has been a long-time critic of vaccines and government health agencies. Kennedy has promised wide-ranging reforms, including a significant shake-up of the Food and Drug Administration (FDA) and a halt to federally funded infectious disease research.
In his initial comments as health secretary, Kennedy reasserted his contention that pharmaceutical interests have undermined regulatory bodies. He pledged to “gut the FDA” and institute more rigorous surveillance of drug approvals and public health initiatives. Medical professionals have been worried by his position, citing that such measures will eliminate public confidence in vaccines and vital health programs.
Kennedy’s proposals to shut down infectious disease research have also been criticized by scientists and international health organizations. They worry such an action could impede work to prevent and contain future pandemics. His supporters, on the other hand, believe his leadership will introduce badly needed transparency and accountability into government health agencies.
As he assumes office, Kennedy is under increasing pressure to explain how his policies will affect national and international public health. His time in office promises to be one of the most contentious in the history of the Department of Health and Human Services, with intense opposition and staunch support defining the path forward.
